India – Medical Devices Policy, 2023 – A Vision To Streamline Regulation, Incentivise Domestic Manufacturing And Facilitate R&D.

India – FIG Paper (No. 21 – Series 1): SEBI’s Mutual Fund Expense Ratio Consultation Paper: Impact Analysis.

- Anu Tiwari - Cyril Amarchand Mangaldas,

India – SEBI Proposes Key Changes To The AIF Regime.

- Vivaik Sharma - Cyril Amarchand Mangaldas, Cyril Amarchand Mangaldas

India – Cyril Amarchand Mangaldas Advises PNB Housing Finance On Its INR 2493 Crore Rights Issue.

India – Unravelling Go Air’s Insolvency Journey: Key Insights And Future Implications.

- Anuroop Omkar - AK & Partners,

India – Spotlight: Why PMLA Scheduled Offences Need A Fresh Look?

- Bharat Vasani - Cyril Amarchand Mangaldas,

India – Cyril Amarchand Mangaldas Advises Abrdn Group On Sale Of 1.66% Stake In HDFC Life Via Block Transactions Aggregating INR 2047 Crore (Approx.).

India – Highlights Of The Master Circular On IRDAI (Registration Of Indian Insurance Companies) Regulations, 2022.

- Indranath Bishnu - Partner, Cyril Amamrchand Mangaldas

Concept To Compliance: Unveiling The Untapped Realm Of Customised Cosmetics Regulation In India.

UK – Hill Dickinson Advises MSS Group On Acquisition By Stellex Capital Management.

India – AKP Banking & Finance Digest- June 12, 2023.

- Anuroop Omkar - AK & Partners,

India – FIG (No.18 – Series 2) RBI’s New Default Loss Guarantee Guidelines: Late But Not Lost.

- Anu Tiwari - Cyril Amarchand Mangaldas,